The mail-to-lab testing kits market is projected to grow from USD 2.3 billion in 2026 to USD 6.5 billion by 2036, at a CAGR of 11.0%. Direct-to-consumer (DTC) will dominate with a 55.0% market share, while preventive health will lead the application segment with a 45.0% share.